Reentered this biotech that got breakthrough FDA approval for its drug in phase 2 and it was starting to look toppy. And I am aware most phase 2 companies that I halve seen only go between 35-50% of the day and it was starting to look toppy so I sold within that same minute for small gains. My entry and exit was correct analysis because it has dropped almost two dollars a share four hours after